Cargando…
5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis
SIMPLE SUMMARY: This retrospective study presents the clinical outcomes of the largest cohort of patients (853 patients) with low-, favorable intermediate-, and unfavorable intermediate-risk prostate cancer treated with ultra-hypofractionated proton beam radiotherapy (36.25 GyE/five fractions). The...
Autores principales: | Kubeš, Jiri, Sláviková, Silvia, Vítek, Pavel, Haas, Alexandra, Ondrová, Barbora, Dedečková, Kateřina, Andrlík, Michal, Domanský, Martin, Jiránková, Kateřina, Schlencová, Veronika, Harazimová, Anh, Turková, Barbora, Doležal, Tomáš, Al-Hamami, Sarah Falah Abass, Vondráček, Vladimír |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526468/ https://www.ncbi.nlm.nih.gov/pubmed/37760540 http://dx.doi.org/10.3390/cancers15184571 |
Ejemplares similares
-
Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer—Single Institution Experience
por: Vítek, Pavel, et al.
Publicado: (2021) -
Pencil‐beam scanning proton therapy for the treatment of glomus jugulare tumours
por: Kubeš, Jiří, et al.
Publicado: (2022) -
Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
por: Ntentas, Georgios, et al.
Publicado: (2019) -
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection
por: Ntentas, Georgios, et al.
Publicado: (2022) -
P068: A Retrospective Analysis of Fertility in Female Patients with Advanced Stages of Hodgkin Lymphoma Treated with BEACOPP Escalated Chemotherapy (25 Year Experience of a Single Centre)
por: Marková, Jana, et al.
Publicado: (2022)